Stay updated on Fostamatinib in wAIHA Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in wAIHA Clinical Trial page.

Latest updates to the Fostamatinib in wAIHA Clinical Trial page
- Check7 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe study record page now shows a 403 Forbidden error, blocking access to the content and preventing the study details from loading.SummaryDifference17%

- Check56 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, representing a change to the page's version history. This update does not alter any study details shown on the page.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision label on the page was updated from v3.6.4 to v3.6.5, signaling a small backend/ CMS update. The change does not affect study content or functionality.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, signaling a new version of the study page. This update indicates a version bump or minor content refresh without changing the displayed study information.SummaryDifference0.0%

Stay in the know with updates to Fostamatinib in wAIHA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in wAIHA Clinical Trial page.